Aspira Women's Health: Sandra Milligan, Todd Pappas, Jody Berry

Aspira Women's Health has appointed Sandra Milligan as president effective April 1, 2024 and promoted Todd Pappas, vice president of research and development, to head the company's product development team following the departure of Jody Berry, who stepped down in March.

Milligan was previously executive vice president, research and development at Organon. Prior to that, she was senior vice president, global regulatory affairs and clinical safety at Merck. She has also held research and development roles at Genentech and Amgen.